Effects of combined glutamate and platelet-activatin factor inhibition on the outcome of focal cerebral ischaemia - An initial screening study

Metabolic Brain Disease

Volumn 12, Issue 3, 1997, Pages 237-249

  Aspey, B S ^a   Alp, M S ^a   Patel, Y ^a   Harrison, M J G ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Glutamate antagonists; Middle cerebral artery occlusion; Neuroprotection; Platelet activating factor

Indexed keywords

BB 823; GLUTAMIC ACID; SIPATRIGINE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY; MOTOR DYSFUNCTION; NONHUMAN; RAT;

ANIMALS; BRAIN ISCHEMIA; CEREBRAL INFARCTION; DRUG COMBINATIONS; GLUTAMIC ACID; LEUCINE; MALE; MOVEMENT DISORDERS; NEUROPROTECTIVE AGENTS; PERIAQUEDUCTAL GRAY; PIPERAZINES; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SODIUM CHANNEL BLOCKERS; TIME FACTORS;

ANIMALIA;

EID: 0030863206     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02674616     Document Type: Article

References (96)

1. Albers, G.W., Goldberg, M.P., and Choi, D.W. (1992). Do NMDA antagonists prevent neuronal injury? Yes. Arch. Neurol. 49:418-420.
2. Angevine, J.B., and Cotman, C.W. (1981). Principles of Neuroanatomy, Oxford University Press, New York.
3. Ashwal, S., Cole, D.J., Osborne, T.N., and Pearce, W.J. (1993). Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model. J. Neurosurg. Anaesthesiol. 5:241-249.
4. Aspey, B.S., Cohen, S., Patel, Y., and Harrison, M.J. (1997). Effects of suture type and rat strain on outcome of the intraluminal suture method: development of a consistent protocol. J. Cereb Blood Flow Metab 17 (suppl. 1): S302.
5. Aspey, B.S., Patel, Y., and Harrison, M.J.G. (1994). Effect of novel PAF antagonist, BB823, on cerebral infarction. Stroke 25:266.
6. Astrup, J., Symon, L., and Siesj̈o, B.K. (1981). Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12:723-725.
7. Auer, R.N. (1995). Combination therapy with U74006F (tirilazad mesylate), MK-801, insulin and diazepam in transient forebrain ischaemia. Neurol. Res. 17:132-136.
8. Back, T., Kohno, K., and Hossmann, K-A. (1994). Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue oxygenation and electroencephalogram. J. Cereb. Blood Flow Metab. 14:12-19.
9. Bederson, J.B., Pitts, L.H., Germano, S.M., Nishimura, M.C., Davis, R.L., and Bartkowski, H. (1986a). Evaluation of 2,3,5-triphenyltetrazoIium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308.
10. Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L., and Bartkowski, H. (1986b). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurological examination. Stroke 17:472-476.
11. Belayev, L., Alonso, B.S., Busto, R., Zhao, W., and Ginsberg, M.D. (1996). Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 27:1616-1623.
12. Benveniste, H., Drejer, J., Schousboe, A., and Diemer, N.H. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1369-1374.
13. Bielenberg, G.W., Wagener, G., and Beck, T. (1992). Infarct reduction by the platelet activating factor antagonist apafant in rats. Stroke 23:98-103.
14. 2+ in hippocampal neurons. Neuron 9:285-294.
15. Boast, C.A., Gerhardt, S.C., and Janak, P. (1987). Systemic AP7 reduces ischaemic damage in gerbils. In (T.P.D. Hicks, D. Lodge, H. McLennan, eds.), Excitatory amino acid transmission, Alan R. Liss, New York, pp. 249-252.
16. Braquet, P., Paubert-Braquet, M., Koltai, M., Bourgain, R., Bussolino, F., and Hosford, D. (1989). Is there a case for PAF antagonists in the treatment of ischemic states? Trends Pharmacol. Sci. 10:23-30.
17. +)ATPase activity in rat brain. Neurosci. Res. 19:241-244.
18. Chan, P.H. (1996). Role of oxidants in ischemic brain damage. Stroke 27:1124-1129.
19. Clark, G.D., Happel, L.T., Zorumski, C.F., and Bazan, N.G. (1992). Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron 9:12211-1216.
20. Coyle, P., and Jokelainen, P.T. (1982). Dorsal cerebral arterial collaterals of the rat. Anat. Rec. 203:397-404.
21. Dawson, D.A. (1994). Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcome. Cerebrovasc. Brain Metab. Rev. 6:299-324.
22. De-Rui, P.L., Demontis, M.P., Anania, V., Caria, M.A., Mameli, O., Becciu, A., and Tolu, E. (1995). Brain electrobiogenesis protection induced by nimodipine and MK-801 during acute hypoxia in hypertensive rats. Pharmacol. Res. 31:169-173.
23. del Zoppo, G.J., Schmid-Schönbein, G.W., Mori, E., Copeland, B.R., and Chang, C.M. (1991). Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22:1276-1283.
24. Dogan A., Suzuki Y., Koketsu N., Osuka K., Saito K., Takayasu M., Shibuya M., and Yoshida J. (1997). Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic injury after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 17:19-25.
25. 3H]PAF binding and PAF concentrations in gerbil brain after bilateral common carotid artery occlusion: a quantitative autoradiographic study. Brain Res. 640:268-276.
26. Drejer, J., Benveniste, H., Diemer, N.H., and Schousboe, A. (1985). Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J. Neurochem. 45:145-151.
27. Duverger, D., and MacKenzie, E.T. (1988). The quantification of cerebral infarction following focal ischaemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J. Cereb. Blood Flow Metab. 8:449-461.
28. Feuerstein, G.Z ., Liu, T., and Barone, F.C. (1994). Cytokines, inflammation and the brain - the role of tumour necrosis factor-a. Cerebrovasc. Brain Metab. Rev. 6:341-360.
29. Flecknell, P.A. (1989). Laboratory animal anaesthesia. An introduction for research workers and technicians. Academic Press, London, pp. 26-30.
30. Frazzini, V.I., Winfree, C.J., Choudhri, H.F., Prestigiacomo, C.J., and Solomon, R.A. (1994). Mild hypothermia and MK-801 have similar but not additive degrees of cerebroprotection in the rat permanent focal ischemia model. Neurosurgery 34:1040-1045.
31. Frerichs, K.U., Lindsberg, P.J., Hallenbeck, J.M., and Feuerstein, G.Z. (1990). Platelet-activating factor and progressive brain damage following focal brain injury. J. Neurosurg. 73:223-233.
32. Furlan, M., Marchal, G., Viader, F., Derlon, J-M., and Baron, J-C. (1996). Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann. Neurol. 40:216-226.
33. Garcia, J.H. (1995). Ischemic stroke after the intrinsic occlusion of the middle cerebral artery (Wistar rat): a review. In (J. Grotta, L.P. Miller, A.M. Buchan, eds.), Recent Advances in the Understanding and Therapy of Ischemic Stroke, IBC (International Business Communications), Southborough, MA, USA, pp.75-91.
34. Garcia, J.H., Liu, K-F., and Ho, K-L. (1995). Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 26:636-643.
35. Garcia, J.H., Liu, K-F., Yoshida, Y., Lian, J., Chen, S., and del Zoppo, G.J. (1994). Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am. J. Pathol. 144:188-199.
36. Gelb, A.W., Zhang, C., Karlik, S., and Hamilton, J.T. (1991). The efficacy of combined MK-801 and lidocaine in temporary feline focal cerebral ischemia. J. Cereb. Blood Flow Metab. 11(suppl.2):S294.
37. Gilboe, D.D., Kinter, D., Fitzpatrick, J.H., Emoto, S.E., Esanu, A., Braquet, and P.G., Bazan, N.G. (1991). Recovery of postischemic brain metabolism and function following treatment with a free radical scavenger and platelet-activating factor antagonists. J. Neurochem. 56:311-319.
38. Gill, R. (1994). The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia. Cerebrovasc. Brain Metab. Rev. 6:225-256.
39. Ginsberg, M.D., and Busto R. (1989). Rodent models of cerebral ischemia. Stroke 20:1627-1642.
40. Graham, S.H., Chen, J., Sharp, F.R., and Simon, R.P. (1993). Limiting ischemic injury by inhibition of excitatory amino acid release. J. Cereb. Blood Flow Metab. 13:88-97.
41. Green, C.J. (1981). Animal anaesthesia, Laboratory Animal Ltd., London, pp. 159-160.
42. Grotta, J. (1995). A glimpse to the future: multitherapy trials. Cerebrovasc. Dis. 5(suppl 1):27-30.
43. Hallenbeck, J.M., and Frerichs, K.U. (1993). Stroke therapy, it may be time for an integrated approach. Arch. Neurol. 50:768-770.
44. Härtl, R., Schürer, L., Schmid-Schönbein, G.W., and del Zoppo, G.J. (1996). Experimental antileukocyte interventions in cerebral ischemia. J. Cereb. Blood Flow Metab. 16:1108-1119.
45. Hatfield, R.H., Gill, R., and Brazell, C. (1992). The dose-response relationship and therapeutic window for dizocilpine (MK-801) in a rat focal ischaemia model. Eur. J. Pharmacol. 216:1-7.
46. Hatfield, R.H,. Mendelow, A.D., Perry, R.H., Alvarez, L.M., and Modha, P. (1991). Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropath. Appl. Neurobiol. 17:61-67.
47. Hossmann, K-A. (1994). Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36:557-565.
48. Humphrey, D.M., Hanahan, D.J., and Pinckard, R.N. (1982). Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine. Lab. Invest. 47:227-234.
49. Isayama, K., Pitts, L.H., and Nishimura, M.C. (1991). Evaluation of 2,3,5 triphenyltetrazolium chloride staining to delineate rat brain infarcts. Stroke 22:1394-1398.
50. Kaku, D.A., Goldberg, M.P., and Choi, D.W. (1991). Antagonism of non-NMDA receptors augments the neuroprotective effect of NMDA receptor blockade in cortical cultures subjected to prolonged deprivation of oxygen and glucose. Brain Res. 554:344-347.
51. Kochanek, P.M., Dutka, A.J., Kumaroo, K.K., and Hallenbeck, J.M. (1987). Platelet-activating factor receptor blockade enhances early neuronal recovery after multifocal brain ischemia in dogs. Life Sciences 41:2639-2644.
52. Kockanek, P.M., and Hollanbeck, J.M. (1992). Polymorphonuclear leucocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23:1367-1379.
53. Koizumi, J., Yoshida, Y., Nakazawa, T., and Ooneda, G. (1986). Experimental studies of ischemic brain edema: 1. a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn. J. Stroke 8:1-8.
54. Kumar, R., Harvey, A.K., Kester, M., Hanahan, D., and Olson, M.S. (1988). Production and effects of platelet activating factor in the rat brain. Biochem. Biophys. Acta 963:375-383.
55. Laing, R.J., Jakubowski, J., and Laing, R.W. (1993). Middle cerebral artery occlusion without craniectomy in rats. Which method works best? Stroke 24:294-298.
56. Leach, M.J., Swan, J.H., Eisenthal, D., Dopson, M., and Nobbs, M. (1993). BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke 24:1063-1067.
57. Lin, T-N., He, Y.Y., Wu, G., Khan, M., and Hsu, C.Y. (1993). Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24:117-121.
58. Lindsberg, P.J., Yue, T-L., Frerichs, K.U., Hallenbeck, J.M., and Feuerstein, G. (1990). Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits. Stroke 21:1452-1457.
59. Lippert, K., Welsch, M., and Krieglstein, J. (1994). Over-additive protective effect of dizocilpine and NBQX against neuronal damage. Eur, J. Pharmacol. 253:207-213.
60. Lorant, D.E., Zimmerman, G.A., McIntyre, T.M., and Prescott, S.M. (1995). Platelet-activating factor mediates procoagulant activity on the surface of endothelial cells by promoting leukocyte adhesion. Sem. Cell Biol. 6:295-303.
61. Lyden, P.D., and Lonzo, L. (1994). Combination therapy protects ischemic brain in rats. A glutamate antagonist plus a gamma-aminobutyric acid agonist. Stroke 25:189-196.
62. McAuley, M.A. (1995): Rodent models of focal ischemia. Cerebrovasc. Brain Metab. Rev. 7:153-180.
63. McDonald, J.W., and Johnston, M.V. (1992). Neuroprotective synergism of 2-amino-3-phosphonoproprionate (D,L-AP3) and MK-801 against ibotenate induced brain injury. Neurosci. Lett. 145:213-216.
64. Memezawa, H., Minamisawa, H., Smith, M.L., and Siesjö, B.K. (1992). Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp. Brain Res. 89:67-78.
65. Meldrum, B. (1990). Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc. Brain Metab. Rev. 2:27-57.
66. Minematsu, K., and Fisher, M. (1993). MK-801 reduces extensive infarction after middle cerebral artery occlusion in rats. Cerebrovasc. Dis. 3:99-104.
67. Mohamed, A.A., Gotoh, O., Graham, D.I., Osborne, K.A., McCulloch, J., Mendelow, A.D. et al. (1985). Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann. Neurol. 18:705-711.
68. Nagasawa, H., and Kogure, K. (1989). Correlation between cerebral blood flow and histologicchanges in a new rat model of middle cerebral artery occlusion. Stroke 20:1037-1043.
69. 14C]2-deoxyglucose phosphorylation. J. Cereb. Blood Flow Metab. 6:607-615.
70. Nishida, K., and Markey, S.P. (1996). Platelet-activating factor in brain regions after transient ischemia in gerbils. Stroke 27:514-519.
71. Oberpichler, H., Sauer, D., Rossberg, C., Mennel, H.D., and Krieglstein, J. (1990). PAF antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus. J. Cereb. Blood Flow Metab. 10:133-135.
72. Obrenovitch, T.P., and Richards, D.A. (1995). Extracellular neurotransmitter changes in cerebral ischaemia. Cerebrovasc. Brain Metab. Rev. 7:1-54.
73. Obrenovitch, T.P., Zilkha, E., and Urenjak, J. (1996). Evidence against high extracellular glutamate promoting the elicitation of spreading depression by potassium. J. Cereb. Blood Flow Metab. 16:923-931.
74. Oliff, H.S., Weber, E., Eilon, G., and Marek, P. (1995). The role of strain/vendor differences on the outcome of focal ischemia induced by intraluminal middle cerebral artery occlusion in the rat. Brain Res. 675:20-26.
75. Olney, J.W., Labruyere, G., Wang, G., Wozniak, D.F., Price, M.T., and Sesma, M.A. (1991). NMDA antagonist neurotoxicity: mechanism and prevention. Science 254:1515-1518.
76. O'Neill, S.K., and Bolger, G.T. (1989). Anticonvulsant activity of MK-801 and nimodipine alone and in combination against pentylenetetrazole and strychnine. Pharmacol. Biochem. Behav. 32:595-600.
77. Osborne, K.A., Shigeno, T., Balarsky, A.M., Ford, I., McCulloch, J., Teasdale, G.M., and Graham, D.I. (1987). Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J. Neurol. Neurosurg. Psychiat. 50:402-410.
78. Park, C.K., Mendelow, A.D., Graham, D.I., McCulloch, J., and Teasdale, G.M. (1988). Correlation of triphenyltetrazolium chloride perfusion staining with conventional neurohistology in the detection of early brain ischaemia. Neuropath. Appl. Neurobiol. 14:289-298.
79. Panetta, T., Marcheselli, V.L., Braquet, P., Spinnewyn, B., and Bazan, N.G. (1987). Effects of a platelet-activating factor antagonist (BN52021) on free fatty acids, diacylglycerols, polyphospho-inositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion-induced cerebral injury. Biochem. Biophys. Res. Comm. 149:580-587.
80. Pulsinelli, W. (1992). Pathophysiology of acute ischaemic stroke. Lancet 339:533-536.
81. Rapaport, S.I., and Thompson, H.K. (1973). Osmotic opening of the blood brain barrier in the monkey without associated neurological deficits. Science 180:971.
82. Rod, M.R., and Auer, R.N. (1992). Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischaemia. Stroke 23:725-732.
83. Schurr, A., Payne, R.S., and Rigor, B.M. (1995). Synergism between diltiazem and MK-801 but not APV in protecting rat hippocampal slices against hypoxic damage. Brain Res. 684:233-236.
84. Siesjö, B., Agardh, C-D., and Bengtsson, F. (1989). Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1:165-211.
85. Smith, S.E., and Meldrum, G. (1995). Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke 26:117-122.
86. Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C., and Sharp, F.R. (1989). A semiautomated method for measured brain infarct volume. J. Cereb. Blood Flow Metab. 10:290-293.
87. 14C]iodoantipyrine autoradiography following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:61-69.
88. Tokutomi, T., Sigemori, M., Kikuchi, T., and Hirohata, M. (1994). Effect of platelet-activating factor antagonist on brain injury in rats. Acta Neurochir. Suppl. Wein 60:508-510.
89. Tyson, G.W., Teasdale, G.M., Graham, D.I., and McCulloch, J. (1984). Focal cerebral ischemia in the rat: topography of hemodynamic and histopathological changes. Ann. Neurol. 15:559-567.
90. Uematsu, D., Araki, N., Greenberg, J., Sladky, J., and Reivich, M. (1991). Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology 41:88-94.
91. Weiss, S.J. (1989). Tissue destruction by neutrophils. N. Engl J. Med. 320:365-376.
92. Whittaker, M., Beauchamp, C.L., Bowles Sackett, K.S., Christodoulou, M.S., Galloway, W.A., Longstaff, D.S., et al. (1992). BB-823, a PAF receptor antagonist with picomolar activity. Pharmacol. Comm. 1:253-257.
93. Yamori, Y., Horie, R., Handa, H., Sato, M., and Fukase, M. (1976). Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7:46-53.
94. 3H]D-aspartate release after ischaemia in vitro. Neuroreport 6:85-88.
95. Zea Longa, E., Weinstein, P.R., Carlson, S., and Cummins, R. (1989). Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
96. Zivin, J.A., and Choi, D.W. (1991). Stroke therapy. Scientific American 265(1):36-43.